100 related articles for article (PubMed ID: 32393580)
1.
Nelson AC; Turbyville TJ; Dharmaiah S; Rigby M; Yang R; Wang TY; Columbus J; Stephens R; Taylor T; Sciacca D; Onsongo G; Sarver A; Subramanian S; Nissley DV; Simanshu DK; Lou E
J Biol Chem; 2020 Jul; 295(28):9335-9348. PubMed ID: 32393580
[TBL] [Abstract][Full Text] [Related]
2. The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.
Johnson CW; Reid D; Parker JA; Salter S; Knihtila R; Kuzmic P; Mattos C
J Biol Chem; 2017 Aug; 292(31):12981-12993. PubMed ID: 28630043
[TBL] [Abstract][Full Text] [Related]
3. Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.
Yan W; Markegard E; Dharmaiah S; Urisman A; Drew M; Esposito D; Scheffzek K; Nissley DV; McCormick F; Simanshu DK
Cell Rep; 2020 Jul; 32(3):107909. PubMed ID: 32697994
[TBL] [Abstract][Full Text] [Related]
4. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C
Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth.
Tang R; Shuldiner EG; Kelly M; Murray CW; Hebert JD; Andrejka L; Tsai MK; Hughes NW; Parker MI; Cai H; Li YC; Wahl GM; Dunbrack RL; Jackson PK; Petrov DA; Winslow MM
Nat Cell Biol; 2023 Jan; 25(1):159-169. PubMed ID: 36635501
[TBL] [Abstract][Full Text] [Related]
6. PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis.
Pan R; Dai J; Liang W; Wang H; Ye L; Ye S; Lin Z; Huang S; Xiong Y; Zhang L; Lu L; Wang O; Shen X; Liao W; Lu X
Cell Death Dis; 2023 Jun; 14(6):373. PubMed ID: 37355626
[TBL] [Abstract][Full Text] [Related]
7. A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.
Simanshu DK; Morrison DK
Cancer Discov; 2022 Apr; 12(4):899-912. PubMed ID: 35046094
[TBL] [Abstract][Full Text] [Related]
8. A structural model of a Ras-Raf signalosome.
Mysore VP; Zhou ZW; Ambrogio C; Li L; Kapp JN; Lu C; Wang Q; Tucker MR; Okoro JJ; Nagy-Davidescu G; Bai X; Plückthun A; Jänne PA; Westover KD; Shan Y; Shaw DE
Nat Struct Mol Biol; 2021 Oct; 28(10):847-857. PubMed ID: 34625747
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of isoform-specific residue influence on GTP-bound HRas, KRas, and NRas.
Volmar AY; Guterres H; Zhou H; Reid D; Pavlopoulos S; Makowski L; Mattos C
Biophys J; 2022 Oct; 121(19):3616-3629. PubMed ID: 35794829
[TBL] [Abstract][Full Text] [Related]
10. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structure Reveals the Full Ras-Raf Interface and Advances Mechanistic Understanding of Raf Activation.
Cookis T; Mattos C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356620
[TBL] [Abstract][Full Text] [Related]
12. Conditional Cooperativity in RAS Assembly Pathways on Nanodiscs and Altered GTPase Cycling.
Lee SY; Lee KY
Angew Chem Int Ed Engl; 2024 Mar; 63(13):e202316942. PubMed ID: 38305637
[TBL] [Abstract][Full Text] [Related]
13. Progress in Targeting KRAS Directly.
Nissley DV; Stephen AG; Yi M; McCormick F
Methods Mol Biol; 2024; 2797():1-12. PubMed ID: 38570448
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Cross Talk between Effector and Allosteric Lobes of KRAS from Methyl Conformational Dynamics.
Chao FA; Dharmaiah S; Taylor T; Messing S; Gillette W; Esposito D; Nissley DV; McCormick F; Byrd RA; Simanshu DK; Cornilescu G
J Am Chem Soc; 2022 Mar; 144(9):4196-4205. PubMed ID: 35213144
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of NRAS Q61K with a ligand-induced pocket near switch II.
Gebregiworgis T; Chan JY; Kuntz DA; Privé GG; Marshall CB; Ikura M
Eur J Cell Biol; 2024 Apr; 103(2):151414. PubMed ID: 38640594
[TBL] [Abstract][Full Text] [Related]
16. Membrane-Driven Dimerization of the Peripheral Membrane Protein KRAS: Implications for Downstream Signaling.
Lee KY
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473778
[TBL] [Abstract][Full Text] [Related]
17. Dynamically encoded reactivity of Ras enzymes: opening new frontiers for drug discovery.
Pálfy G; Menyhárd DK; Perczel A
Cancer Metastasis Rev; 2020 Dec; 39(4):1075-1089. PubMed ID: 32815102
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation.
Chen PY; Huang BJ; Harris M; Boone C; Wang W; Carias H; Mesiona B; Mavrici D; Kohler AC; Bollag G; Zhang C; Zhang Y; Shannon K
JCI Insight; 2023 Sep; 8(17):. PubMed ID: 37681415
[TBL] [Abstract][Full Text] [Related]
19. Drugging all RAS isoforms with one pocket.
Kessler D; Bergner A; Böttcher J; Fischer G; Döbel S; Hinkel M; Müllauer B; Weiss-Puxbaum A; McConnell DB
Future Med Chem; 2020 Nov; 12(21):1911-1923. PubMed ID: 32779487
[TBL] [Abstract][Full Text] [Related]
20. Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib.
Riancho JA; Hernández JL; González-Vela C; López-Sundh AE; González-Lopez MA; Gomez de la Fuente F; Quirce R; Diamond EL
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
